Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Yttrium (90Y) Clivatuzumab Tetraxetan Biosimilar, Radiolabelled Antibody, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/ |
yttrium (90Y) clivatuzumab tetraxetan |
NA |
MUC1 |
Radiolabelled antibody |
||
Pre-Made Yttrium (90Y) Tacatuzumab Tetraxetan Biosimilar, Radiolabelled Antibody, Anti-Afp Antibody: Anti-AFPD/FETA/HPAFP therapeutic antibody |
yttrium (90Y) tacatuzumab tetraxetan |
NA |
AFP |
Radiolabelled antibody |
||
Pre-Made Zanidatamab Zovodotin B Zovodotiniosimilar, Bispecific/Biparatopic, Anti-ERBB2/HER2;ERBB2/HER2 Therapeutic/Biparatopic Antibody Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 1 |
zanidatamab zovodotin |
NA |
ERBB2,ERBB2 |
Bispecific/biparatopic |
||
Pre-Made Zilovertamab Vedotin Biosimilar, Whole Mab Adc, Anti-Ror1 Antibody: Anti-NTRKR1/dJ537F10.1 therapeutic antibody Drug Conjugate |
zilovertamab vedotin |
NA |
ROR1 |
Whole mAb ADC |
||
Pre-Made Zimbirelimab Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
zimbirelimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Ziralimumab Biosimilar, Whole Mab, Anti-Bsg Antibody: Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF therapeutic antibody |
ziralimumab |
NA |
BSG |
Whole mAb |
||
Pre-Made Zolimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody |
zolimomab aritox |
NA |
CD5 |
ADC |
||
Pre-Made Abatacept Biosimilar, Fusion Protein targeting CTLA4/CTLA-4 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 |
abatacept |
NA |
ctla-4 |
Fusion Protein |
||
Pre-Made Abciximab Biosimilar, Fab Fusion, Anti-Itga2B/Itgb3 Antibody: Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2 therapeutic ant |
abciximab |
NA |
ITGA2B/ITGB3 |
Fab Fusion |
||
Pre-Made Acazicolcept Biosimilar, Fusion Protein targeting CD28 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting Tp44 |
acazicolcept |
NA |
CD28 |
Fusion Protein |
||
Pre-Made Actinium (225Ac) Lintuzumab Satetraxetan Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody: Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody Drug Conjugate |
actinium (225Ac) lintuzumab satetraxetan |
NA |
CD33 |
Whole mAb ADC |
||
Pre-Made Adalimumab Beta Biosimilar, Whole Mab, Anti-Tnf Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody |
adalimumab beta |
NA |
TNF |
Whole mAb |
||
Pre-Made Adecatumumab Biosimilar, Whole Mab, Anti-Epcam Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody |
adecatumumab |
NA |
EPCAM |
Whole mAb |
||
Pre-Made Afelimomab Biosimilar, Fab Fusion, Anti-Tnf Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody |
afelimomab |
NA |
TNF |
Fab Fusion |
||
Pre-Made Aflibercept Biosimilar, Fusion Protein targeting VEGFA fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting MVCD1/VEGF/VPF |
aflibercept |
NA |
VEGFA |
Fusion Protein |
||
Pre-Made Albiglutide Biosimilar, Peptide Protein Fusion targeting GLP1R: (Glp-1)2 Peptide-Albumin(Alb) Fusion Protein targetingGLP-1-R/GLP-1R |
albiglutide |
NA |
GLP1R |
Peptide Protein fusion |
||
Pre-Made Albinterferon Alfa- 2B Biosimilar, Fusion Protein targeting IFNAR1 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR |
albinterferon alfa- 2b |
NA |
IFNAR1 |
Fusion Protein |
||
Pre-Made Albutrepenonacog Alfa Biosimilar, Fusion Protein targeting F9 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 |
albutrepenonacog alfa |
NA |
F9 |
Fusion Protein |
||
Pre-Made Aldafermin Biosimilar, Recombinant Protein targeting FGFR4: Recombinant therapeutic protein targeting CD334/JTK2/TKF |
aldafermin |
NA |
FGFR4 |
Recombinant Protein |
||
Pre-Made Aldesleukin biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting IL2 |
aldesleukin |
NA |
IL2 |
Recombinant Protein |
||
Pre-Made Alefacept Biosimilar, Fusion Protein targeting CD2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting LFA-2/SRBC/T11 |
alefacept |
NA |
CD2 |
Fusion Protein |
||
Pre-Made Altumomab Biosimilar, Radiolabelled Antibody, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody |
altumomab |
NA |
CEACAM5 |
Radiolabelled antibody |
||
Pre-Made Alvircept Sudotox biosimilar, Fusion Protein: Recombinant therapeutic protein targeting HIV-1 gp120 fused with Pseudomonas aeruginosa exotoxin A |
alvircept sudotox |
NA |
HIV-1 gp120 |
Fusion Protein |
||
Pre-Made Anakinra Biosimilar, Recombinant Protein targeting IL1R1: Recombinant therapeutic protein targeting CD121A/D2S1473/IL-1R-alpha/IL1R/IL1RA/P80 Pre-made [INN Name] Biosimilar, [Format] target |
anakinra |
NA |
IL1R1 |
Recombinant Protein |
||
Pre-Made Anatumomab Mafenatox biosimilar, Fusion Protein: Anatumomab-Anti-TAG-72 therapeutic antibody fused with Staphylococcus aureus enterotoxin A |
anatumomab mafenatox |
NA |
TAG-72 |
Fusion Protein |
||
Pre-Made Anetumab Corixetan Biosimilar, Whole Mab Adc, Anti-Msln Antibody: Anti-MPF/SMRP therapeutic antibody Drug Conjugate |
anetumab corixetan |
NA |
MSLN |
Whole mAb ADC |
||
Pre-Made Anetumab Ravtansine Biosimilar, Whole Mab Adc, Anti-Msln Antibody: Anti-MPF/SMRP therapeutic antibody Drug Conjugate |
anetumab ravtansine |
NA |
MSLN |
Whole mAb ADC |
||
Pre-Made Apolizumab Biosimilar, Whole Mab, Anti-HLA-DRB/HLA-DRB1 Antibody: Anti-DRB1/SS1 therapeutic antibody |
apolizumab |
NA |
HLA-DRB |
Whole mAb |
||
Pre-Made Aprutumab Ixadotin Biosimilar, Whole Mab Adc, Anti-Fgfr2 Antibody: Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25 therapeutic antibody Drug Conjugate |
aprutumab ixadotin |
NA |
FGFR2 |
Whole mAb ADC |
||
Pre-Made Arcitumomab Biosimilar, Radiolabelled Antibody, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody |
arcitumomab |
NA |
CEACAM5 |
Radiolabelled antibody |
||
Pre-Made Aselizumab Biosimilar, Whole Mab, Anti-Sell Antibody: Anti-CD62L/LAM1/LECAM1/LEU8/LNHR/LSEL/LYAM1/PLNHR/TQ1 therapeutic antibody |
aselizumab |
NA |
SELL |
Whole mAb |
||
Pre-Made Asfotase Alfa biosimilar, Fusion Protein: Recombinant therapeutic protein targeting Enzyme fused with human IGHG1 Fc (Fragment constant) |
asfotase alfa |
NA |
Enzyme |
Fusion Protein |
||
Pre-Made Asunercept Biosimilar, Fusion Protein targeting FASLG/CD178 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting ALPS1B/APT1LG1/APTL/CD95-L/CD95L/FASL/TNF |
asunercept |
NA |
FASLG |
Fusion Protein |
||
Pre-Made Atacicept Biosimilar, Fusion Protein targeting TNFSF13/APRIL fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/ |
atacicept |
NA |
TNFSF13 |
Fusion Protein |
||
Pre-Made Atorolimumab Biosimilar, Whole Mab, Anti-Rhd Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody |
atorolimumab |
NA |
RHD |
Whole mAb |
||
Pre-Made Azintuxizumab Vedotin Biosimilar, Whole Mab Adc, Anti-SLAMF7/CS1 Antibody: Anti-19A/CD319/CRACC therapeutic antibody Drug Conjugate |
azintuxizumab vedotin |
NA |
SLAMF7 |
Whole mAb ADC |
||
Pre-Made Balugrastim Biosimilar, Fusion Protein targeting CSF3R/G-CSF-R fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting CD114/GCSFR/SCN7 |
balugrastim |
NA |
CSF3R |
Fusion Protein |
||
Pre-Made Baminercept Biosimilar, Fusion Protein targeting LTA fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting LT/TNFB/TNFSF1/TNLG1E |
baminercept |
NA |
LTA |
Fusion Protein |
||
Pre-Made Batiraxcept Biosimilar, Fusion Protein targeting GAS6 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AXLLG/AXSF |
batiraxcept |
NA |
GAS6 |
Fusion Protein |
||
Pre-Made Bectumomab Biosimilar, Fab Fusion, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody |
bectumomab |
NA |
CD22 |
Fab Fusion |
||
Pre-Made Belantamab Mafodotin Biosimilar, Whole Mab Adc, Anti-Tnfrsf17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibody Drug Conjugate |
belantamab mafodotin |
NA |
TNFRSF17 |
Whole mAb ADC |
||
Pre-Made Belatacept Biosimilar, Fusion Protein targeting CD80 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting B7/B7-1/B7.1/BB1/CD28LG/CD28LG1/LAB7 |
belatacept |
NA |
CD80 |
Fusion Protein |
||
Pre-Made Bertilimumab Biosimilar, Whole Mab, Anti-Ccl11 Antibody: Anti-SCYA11 therapeutic antibody |
bertilimumab |
NA |
CCL11 |
Whole mAb |
||
Pre-Made Besilesomab Biosimilar, Radiolabelled Antibody, Anti-Ceacam8/NCA-95 Antibody: Anti-CD66b/CD67/CGM6 therapeutic antibody |
besilesomab |
NA |
CEACAM8 |
Radiolabelled antibody |
||
Pre-Made Bevacizumab Beta Biosimilar, Whole Mab, Anti-Vegfa Antibody: Anti-MVCD1/VEGF/VPF therapeutic antibody |
bevacizumab beta |
NA |
VEGFA |
Whole mAb |
||
Pre-Made Bevifimod biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting Staphylococcal protein A |
bevifimod |
NA |
Staphylococcal protein A |
Recombinant Protein |
||
Pre-Made Biciromab Biosimilar, Radiolabelled Antibody: Anti-Fibrin Ii therapeutic antibody |
biciromab |
NA |
fibrin II |
Radiolabelled antibody |
||
Pre-Made Bifarcept Biosimilar, Recombinant Protein targeting IFNA1: Recombinant therapeutic protein targeting IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D |
bifarcept |
NA |
IFNA1 |
Recombinant Protein |
||
Pre-Made Bifikafusp Alfa Biosimilar, Fusion Protein targeting FN/FN1 fused with human IL2 (interleukin 2, IL-2) Pr21-153 (100%) (1:1), noncovalent dimer: Recombinant therapeutic protein targeting CIG |
bifikafusp alfa |
NA |
FN |
Fusion Protein |
||
Pre-Made Bintrafusp Alfa Biosimilar, Fusion Protein targeting CD274/PD-L1 fused with human TGFBR2 (transforming growth factor beta receptor 2) (1:2) via a peptidyl linker: Recombinant therapeutic pro |
bintrafusp alfa |
NA |
CD274 |
Fusion Protein |
